Molina Healthcare (MOH) Announces Preliminary Results For Q2 2025

Molina Healthcare, Inc. (NYSE:MOH) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On July 7, Molina Healthcare, Inc. (NYSE:MOH) announced its preliminary financial results for the fiscal second quarter of 2025 along with an update to its full-year EPS guidance.

As per the latest update, Molina Healthcare, Inc. (NYSE:MOH) expects second quarter earnings around $5.50 per share, reflecting a modest decline from the previous expectation. The decline is due to the medical cost pressure across all three lines of business. Management noted that this pressure is expected to stay for the rest of the year.

As a result, the company also adjusted its full-year 2025 earnings outlook. Molina Healthcare, Inc. (NYSE:MOH) now expects to earn between $21.50 and $22.50 per share for the year. This range is at the low end of its long-term targets. The company’s CEO, Joseph Zubretsky, explained the situation, noting the short-term drop in earnings was due to a gap between how fast medical costs are rising and how quickly premium rates are adjusted. He called this a temporary issue and noted that the company’s long-term outlook is unchanged, even with possible effects from new budget laws.

Molina Healthcare, Inc. (NYSE:MOH) is a managed care company that provides health insurance and healthcare services mainly through government programs like Medicaid and Medicare.

While we acknowledge the potential of MOH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.